Workflow
Duchenne muscular dystrophy treatment
icon
搜索文档
Today's Top Stock Declines: Clinical Trials, Earnings Misses, and Legal Probes Drive Selloffs
Financial Modeling Prep· 2026-05-08 09:00
The market saw significant downward movement in several stocks today. Leading the decline is TRDA (NASDAQ: TRDA), which fell 57.27% to close at $6.85. The biotechnology firm's stock saw a massive trading volume of over 4.11 million shares. This selloff follows the release of clinical trial data for its Duchenne muscular dystrophy treatment. In the technology sector, Fastly (NYSE: FSLY) fell 38.23% to $19.50. The drop occurred on an exceptionally high volume of over 46.74 million shares, despite Fastly repor ...